Wu Kai-da, Moore Malcolm A S
Cell Biology Program, Sloan-Kettering Cancer Institute, New York, NY, USA.
Methods Mol Med. 2005;113:207-23. doi: 10.1385/1-59259-916-8:207.
Telomerase is an enzyme that has been attracting much attention in recent years because its activities are so central to the processes of malignant transformation. It is a reverse transcriptase enzyme that can synthesize telomeric DNA using its own RNA component as a template. Without telomerase, telomeres will shorten until, at a critical length, cells enter senescence and die. The low level or absence of telomerase activity in most nonneoplastic tissues and somatic cells, and its presence in almost all malignant tumors is thus of great interest for potential diagnostic, prognostic, and therapeutic applications in the management of human cancer. It has been documented that high telomerase activity and short telomere length correlate with poor prognosis in patients with multiple myeloma, and antitelomerase therapy has become a novel therapeutic approach for the disease. Thus, determination of telomerase activity and telomere length is essential in the study of cancer. In this chapter, we provide a standard telomeric repeat amplification protocol for telomerase activity assay and a Southern blot terminal restriction fragment protocol for telomere length assay. We also discuss comparison with related assay methods.
端粒酶是一种近年来备受关注的酶,因为其活性在恶性转化过程中至关重要。它是一种逆转录酶,能够以自身的RNA组分为模板合成端粒DNA。如果没有端粒酶,端粒就会缩短,直到达到临界长度,细胞进入衰老并死亡。因此,大多数非肿瘤组织和体细胞中端粒酶活性水平较低或缺乏,而几乎所有恶性肿瘤中都存在端粒酶,这对于人类癌症管理中的潜在诊断、预后和治疗应用具有极大的意义。据记载,多发性骨髓瘤患者中端粒酶活性高和端粒长度短与预后不良相关,抗端粒酶治疗已成为该疾病的一种新型治疗方法。因此,端粒酶活性和端粒长度的测定在癌症研究中至关重要。在本章中,我们提供了用于端粒酶活性测定的标准端粒重复序列扩增方案以及用于端粒长度测定的Southern印迹末端限制性片段方案。我们还讨论了与相关检测方法的比较。